Claudio D'Angelo, Managing Director at Spex Capital, London, England, United Kingdom — verified investor profile. See contact routes.
Spex Capital identifies, supports, and invests in early-stage companies to commercialise and scale globally. They have launched the Spex Venture Health-Tech Fund, a new €100M global fund devised to identify, partner with, and fund the next generation of early-stage digital healthcare and med-tech start-ups. They leverage their healthcare sector expertise across the entire investee company journey.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in London.
Investors like Claudio D'Angelo · Full investor directory · Investor access · Company funding database